ConductScience.org, home

Gene · 1830

Papers2,614

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

121 to 140 of 2,614

Download this page as JSON
TitleJournalYearPMIDFound bySource
Differential Expression of Hard Tissue Proteins in Hypomineralized Second Primary Molars in Comparison to Normal Teeth.Clin Exp Dent Res202539898784PubTator, text miningPubMed
An observational study to determine the role of indirect immunofluorescence and ELISA for desmogleins in the diagnosis and monitoring of autoimmune bullous disorders.Med J Armed Forces India202539872186PubTator, text miningPubMed
Use of multivariant enzyme-linked immunosorbent assay (ELISA) in the diagnosis of autoimmune bullous disorders in a resource-limited setting: A single-center experience.Indian J Dermatol Venereol Leprol202539635793PubTator, text miningPubMed
Direct immunofluorescence on plucked hair outer root sheath can predict relapse in pemphigus vulgaris.Int J Dermatol202539086016PubTator, text miningPubMed
Clinical and immunological predictors of post-rituximab paradoxical pemphigus flare: A prospective cohort study.Indian J Dermatol Venereol Leprol202538595008PubTator, text miningPubMed
The impact of signaling pathways on the desmosome ultrastructure in pemphigus.Front Immunol202439882246PubTator, text miningPubMed
Case report: A rollercoaster journey of pemphigus vegetans.Front Immunol202439872528PubTator, text miningPubMed
Comparison of BIOCHIP Mosaic Based Indirect Immunofluorescence and Oral Direct Immunofluorescence in Patients with Oral Mucosal Pemphigus.Indian Dermatol Online J202439640450PubTator, text miningPubMed
Fermatean fuzzy score function and distance measure based group decision making framework for household waste recycling plant location selection.Sci Rep202439548137PubTator, text miningPubMed
Identification of basement membrane-related prognostic model associated with the immune microenvironment and synthetic therapy response in pancreatic cancer: integrated bioinformatics analysis and clinical validation.
J Cancer202439513120PubTator, text miningPubMed
Pemphigus relapse: Mechanisms, risk factors, and agents associated with disease recurrence.J Dermatol202439460496PubTator, text miningPubMed
Quality-controlled characterization of a monoclonal antibody specific to an EC5-domain of human desmoglein 3 for pemphigus research.Front Immunol202439450179PubTator, text miningPubMed
Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes.Front Immunol202439450168PubTator, text miningPubMed
IgG reactivity to different desmoglein-3 ectodomains in pemphigus vulgaris: novel panels for assessing disease severity.Front Immunol202439416775PubTator, text miningPubMed
Human dental mesenchymal stem cells restorate immune response in sera of pemphigus vulgaris patients.Arch Dermatol Res202439352524PubTator, text miningPubMed
3D Printing in Biocatalysis and Biosensing: From General Concepts to Practical Applications.Chem Asian J202439340791PubTator, text miningPubMed
Unbiased screening identifies regulators of cell-cell adhesion and treatment options in pemphigus.Nat Commun202439271654PubTator, text miningPubMed
Comparison of serum cytokines and chemokines levels and clinical significance in patients with pemphigus vulgaris-A retrospective study.Exp Dermatol202439246287PubTator, text miningPubMed
Bioinks and biofabrication techniques for biosensors development: A review.Mater Today Bio202439205870PubTator, text miningPubMed
Standardized Production of Anti-Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research.Curr Protoc202439169810PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1830/papers?page=7